Gordian Surgical, an Israeli developer of a trocar that offers surgeons a solution for opening and suturing (closing) internal incisions made during laparoscopic surgery, completed a raise nearing $1m.
Backers included Virtus Inspire Ventures, a Chinese venture capital firm, and U.S. laparoscopic surgeons including Prof. Barry Salky, and other investors.
The company will use the funds to complete American (FDA) and European (CE) regulatory processes, start first-in-man (clinical) trials, and prepare for market penetration.
Led by Zvi Pe’er, CEO, Gordian Surgical develops a trocar for surgeons to open and close internal incisions made during laparoscopic surgery. The “two-in-one” trocar inserts sutures into the tissue surrounding the incision at the beginning of the procedure and anchors them to stay in place throughout the operation.
The built-in closure mechanism enables surgeons to close the sutures when the trocar is removed at the end of the procedure.
Gordian is a portfolio company of Trendlines Medical.